Business Description
Beijing Tri Prime Gene Pharmaceutical Co Ltd
ISIN : CNE100004918
Total Employee Number:
246Compare
Compare
Traded in other countries / regions
920344.China IPO Date
2021-01-08Description
Beijing Tri Prime Gene Pharmaceutical Co Ltd is mainly engaged in the research, development, production, and sales of medical biotechnology products, including genetic engineering drugs, genetic engineering vaccines, and diagnostic reagents, and is engaged in related technical trade and technical consulting services. Its product line comprises Yundex Spray, Yundex Eye Drops, Yundexol Powder Injection, and Yundexol Water Injection.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.24 | |||||
Equity-to-Asset | 0.52 | |||||
Debt-to-Equity | 0.82 | |||||
Debt-to-EBITDA | 16.16 | |||||
Interest Coverage | 2.9 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 2.89 | |||||
Beneish M-Score | -2.74 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 17.4 | |||||
3-Year EBITDA Growth Rate | 8.2 | |||||
3-Year EPS without NRI Growth Rate | -43 | |||||
3-Year Book Growth Rate | 2.9 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 53.21 | |||||
9-Day RSI | 47.7 | |||||
14-Day RSI | 47.19 | |||||
3-1 Month Momentum % | -6.97 | |||||
6-1 Month Momentum % | -19.59 | |||||
12-1 Month Momentum % | -45.04 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.74 | |||||
Quick Ratio | 1.61 | |||||
Cash Ratio | 0.77 | |||||
Days Inventory | 142.34 | |||||
Days Sales Outstanding | 81.32 | |||||
Days Payable | 184.97 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 78.97 | |||||
Operating Margin % | 11.78 | |||||
Net Margin % | 6.13 | |||||
EBITDA Margin % | 10.56 | |||||
FCF Margin % | 18.83 | |||||
OCF Margin % | 28.47 | |||||
ROE % | 2.99 | |||||
ROA % | 1.53 | |||||
ROIC % | 3.07 | |||||
3-Year ROIIC % | -1.59 | |||||
ROC (Joel Greenblatt) % | 3.97 | |||||
ROCE % | 3.01 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 123.66 | |||||
PE Ratio without NRI | 116.68 | |||||
Shiller PE Ratio | 55.55 | |||||
PS Ratio | 7.93 | |||||
PB Ratio | 3.6 | |||||
Price-to-Tangible-Book | 5.35 | |||||
Price-to-Free-Cash-Flow | 47.44 | |||||
Price-to-Operating-Cash-Flow | 28.99 | |||||
EV-to-EBIT | 81.21 | |||||
EV-to-EBITDA | 81.21 | |||||
EV-to-Revenue | 8.57 | |||||
EV-to-FCF | 45.54 | |||||
Price-to-GF-Value | 0.72 | |||||
Price-to-Graham-Number | 5.25 | |||||
Earnings Yield (Greenblatt) % | 1.23 | |||||
FCF Yield % | 2.52 | |||||
Forward Rate of Return (Yacktman) % | -14.28 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Beijing Tri Prime Gene Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 301.07 | ||
| EPS (TTM) (Â¥) | 0.15 | ||
| Beta | 1.4017 | ||
| 3-Year Sharpe Ratio | 0.25 | ||
| 3-Year Sortino Ratio | 0.43 | ||
| Volatility % | 25.96 | ||
| 14-Day RSI | 47.19 | ||
| 14-Day ATR (Â¥) | 1.102116 | ||
| 20-Day SMA (Â¥) | 19.1935 | ||
| 12-1 Month Momentum % | -45.04 | ||
| 52-Week Range (Â¥) | 17.27 - 36.68 | ||
| Shares Outstanding (Mil) | 121.81 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Beijing Tri Prime Gene Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Beijing Tri Prime Gene Pharmaceutical Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Beijing Tri Prime Gene Pharmaceutical Co Ltd Frequently Asked Questions
What is Beijing Tri Prime Gene Pharmaceutical Co Ltd(BJSE:920344)'s stock price today?
The current price of BJSE:920344 is ¥18.55. The 52 week high of BJSE:920344 is ¥36.68 and 52 week low is ¥17.27.
When is next earnings date of Beijing Tri Prime Gene Pharmaceutical Co Ltd(BJSE:920344)?
The next earnings date of Beijing Tri Prime Gene Pharmaceutical Co Ltd(BJSE:920344) is .
Does Beijing Tri Prime Gene Pharmaceutical Co Ltd(BJSE:920344) pay dividends? If so, how much?
Beijing Tri Prime Gene Pharmaceutical Co Ltd(BJSE:920344) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Beijing Tri Prime Gene Pharmaceutical Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers